Implanet S.A. (EPA:ALIMP)

Market Cap	25.34M +101.8%
Revenue (ttm)	12.47M +32.6%
Net Income	-4.38M
EPS	-0.03
Shares Out	143.82M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	32,029
Open	0.1842
Previous Close	0.1762
Day's Range	0.1758 - 0.1842
52-Week Range	0.0800 - 0.4500
Beta	0.62
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 15, 2026

About Implanet

Implanet S.A., together with its subsidiaries, manufactures and sells implants and medical instruments for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products, including Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Olea, Saxxo, Swingo, Shark, Origin, and Jazz Frame, as well as ISS-Jazz Screw systems for posterior fixation. It also provides an ultrasonic osteotomy surgical system; and knee prostheses under the Madison name. The co...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Employees: 46
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALIMP

Financial Performance

In 2025, Implanet's revenue was 12.47 million, an increase of 32.62% compared to the previous year's 9.41 million. Losses were -4.38 million, 0.37% more than in 2024.